Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors
Overall survival depends on tumor subtype and systemic treatment. a... | Download Scientific Diagram
Cancers | Free Full-Text | Breast Cancer in Elderly Caucasian Women—An Institution-Based Study of Correlation between Breast Cancer Prognostic Markers, TNM Stage, and Overall Survival
Breast Cancer Subtypes And Prognosis | BCTT
PinPointcases - INACTIVE --- Adjuvant systemic treatment of luminal A/B early breast cancer
Frontiers | High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
Nomogram Model of LNR Predicts Survival in Premenopausal Patients with Node-positive Luminal Breast Cancer | Anticancer Research
Survival curves in the luminal A (a), luminal B (b), HER2 (c), and... | Download Scientific Diagram
Les 12 questions les plus souvent posées sur le cancer du #sein en consultation - HC Ceuta, Centro Médico de Especialidades | Centro Médico de Especialidades
Long-term survival and stage I breast cancer subtypes - ScienceDirect
Survival curves of breast cancer patients stratified by TIL count in... | Download Scientific Diagram
Les 12 questions les plus souvent posées sur le cancer du #sein en consultation - HC Ceuta, Centro Médico de Especialidades | Centro Médico de Especialidades
Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients | Breast Cancer Research and Treatment
Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China | BMC Cancer | Full Text
Breast Cancer Subtypes And Prognosis | BCTT
E2F4 scores in different molecular subtypes of breast c | Open-i
The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study | Cancer Communications | Full Text
Kaplan–Meier overall survival by breast cancer subtypes. 5-year overall... | Download Scientific Diagram
Relapse-free survival in luminal A-like versus luminal B-like breast... | Download Scientific Diagram
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature | JCO Precision Oncology
Cancers | Free Full-Text | Breast Cancer in Elderly Caucasian Women—An Institution-Based Study of Correlation between Breast Cancer Prognostic Markers, TNM Stage, and Overall Survival
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score - Yang - 2023 - Cancer Medicine - Wiley Online Library
Disease-free survival curves of luminal type A and B breast cancer. | Download Scientific Diagram
